Management of Coronary Disease in Patients with Advanced Kidney Disease
2020; Massachusetts Medical Society; Volume: 382; Issue: 17 Linguagem: Inglês
10.1056/nejmoa1915925
ISSN1533-4406
AutoresSripal Bangalore, David J. Maron, Sean M. O’Brien, Jerome L. Fleg, Еvgeny Kretov, Carlo Briguori, Upendra Kaul, Harmony R. Reynolds, Tomasz Mazurek, Mandeep S. Sidhu, Jeffrey S. Berger, Roy O. Mathew, O.L. Bockeria, Samuel Broderick, Radosław Pracoń, Charles A. Herzog, Zhen Huang, Gregg W. Stone, William E. Boden, Jonathan Newman, Ziad A. Ali, Daniel B. Mark, John A. Spertus, Karen P. Alexander, Bernard R. Chaitman, Glenn M. Chertow, Judith S. Hochman,
Tópico(s)Peripheral Artery Disease Management
ResumoClinical trials that have assessed the effect of revascularization in patients with stable coronary disease have routinely excluded those with advanced chronic kidney disease.
Referência(s)